Lag-3 Inhibitors: Climbing the Ladder of Success in Advanced Cancers Lag-3 Inhibitors Are on Track to Become Effective Team Players in Cancer Immunotherapy
Recorded Courses
hosted byProjects In Knowledge Inc. (PIK)
hosted byProjects In Knowledge Inc. (PIK)
attend it anywhere online
category
Medicine, Nursing, Healthcare Management
Oncology
price
Free
Lag-3 Inhibitors: Climbing the Ladder of Success in Advanced Cancers Lag-3 Inhibitors Are on Track to Become Effective Team Players in Cancer Immunotherapy is organized by Projects In Knowledge Inc. (PIK).
Release Date: 5/29/2023
Termination Date:5/28/2024
Activity Goal:
The goal of this program is to provide the most current clinical information and practical management strategies of treating melanoma, colorectal carcinoma, and other cancers, as seen in clinical practice, in a customized, interactive, and easily digestible on-demand educational program.
Learning Objective(s):
Evaluate recent clinical findings for immune checkpoint inhibitor regimens that target LAG-3
Additional details will be posted as soon as information is available.